Jazz Pharmaceuticals PLC (JAZZ): Today's Featured Health Care Laggard
(
) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.7%. By the end of trading, Jazz Pharmaceuticals fell $1.04 (-1.4%) to $72.75 on average volume. Throughout the day, 1,154,966 shares of Jazz Pharmaceuticals exchanged hands as compared to its average daily volume of 988,600 shares. The stock ranged in price between $70.33-$74.10 after having opened the day at $73.96 as compared to the previous trading day's close of $73.79. Other companies within the Health Care sector that declined today were:
(
), down 34.6%,
(
), down 13.0%,
(
), down 12.3% and
(
), down 7.8%.
Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products for various medical needs in the United States, Europe, and other countries. Jazz Pharmaceuticals has a market cap of $4.3 billion and is part of the drugs industry. Shares are up 36.7% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Jazz Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold.
TheStreet Ratings rates
Jazz Pharmaceuticals
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.
- You can view the full Jazz Pharmaceuticals Ratings Report.
On the positive front,
(
), up 19.5%,
(
), up 15.9%,
(
), up 15.3% and
(
), up 15.0% , were all gainers within the health care sector with
(
) being today's featured health care sector leader.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
Health Care Select Sector SPDR
(
) while those bearish on the health care sector could consider
ProShares Ultra Short Health Care
(
).
- Find other investment ideas from our top rated ETFs lists.
null